EUVIMEDEUVIMED entdecken
Crossref

Simvastatin inhibits hepatic stellate cells activation by regulating the ferroptosis signaling pathway

Kensuke Kitsugi, Hidenao Noritake, Moe Matsumoto, Tomohiko Hanaoka, Masahiro Umemura, Maho Yamashita, Shingo Takatori, Jun Ito, Kazuyoshi Ohta, Takeshi Chida, Takafumi Suda, Kazuhito Kawata

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2023-10 · 1869 (7) · 166750

DOI: 10.1016/j.bbadis.2023.166750 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2023-10. Verfasst von Kensuke Kitsugi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatology, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan. Electronic address: 412…. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Ferroptosis. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 75 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Ferroptosis is a form of regulated cell death and its promotion in hepatic stellate cells (HSCs) attenuates liver fibrosis. Statins, which are 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, may induce ferroptosis via the downregulation of glutathione peroxidase 4 (GPX4) by inhibiting the mevalonate pathway. However, little evidence is available regarding the association between statins and ferroptosis. Therefore, we investigated the association between statins and ferroptosis in HSCs. METHODS: Two human HSC cell lines, LX-2 and TWNT-1, were treated with simvastatin, an HMG-CoA reductase inhibitor. Mevalonic acid (MVA), farnesyl pyrophosphate (FPP), and geranylgeranyl pyrophosphate (GGPP) were used to determine the involvement of the mevalonate pathway. We performed a detailed analysis of the ferroptosis signaling pathway. We also investigated human liver tissue samples from patients with nonalcoholic steatohepatitis to clarify the effect of statins on GPX4 expression. RESULTS: Simvastatin reduced cell mortality and inhibited HSCs activation, accompanied by iron accumulation, oxidative stress, lipid peroxidation, and reduced GPX4 protein expression. These results indicate that simvastatin inhibits HSCs activation by promoting ferroptosis. Furthermore, treatment with MVA, FPP, or GGPP attenuated simvastatin-induced ferroptosis. These results suggest that simvastatin promotes ferroptosis in HSCs by inhibiting the mevalonate pathway. In human liver tissue samples, statins downregulated the expression of GPX4 in HSCs without affecting hepatocytes. CONCLUSIONS: Simvastatin inhibits the activation of HSCs by regulating the ferroptosis signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsFerroptosisHumansSimvastatinHepatic Stellate CellsMevalonic AcidSignal Transduction

Stichwörter der Autor:innen

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitorsGlutathione peroxidase 4Liver fibrosisMevalonic acidNonalcoholic steatohepatitis

Substanzen

SimvastatinHydroxymethylglutaryl-CoA Reductase InhibitorsMevalonic Acid

Autor:innen und Institutionen

  • Division of Hepatology, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan. Electronic address: 41233352@hama-med.ac.jp.
  • Division of Hepatology, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
  • Division of Respiratory Medicine, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.

Zitieren

APA

Kitsugi, K., Noritake, H., Matsumoto, M., Hanaoka, T., Umemura, M., Yamashita, M., Takatori, S., Ito, J., Ohta, K., Chida, T., Suda, T., & Kawata, K. (2023). Simvastatin inhibits hepatic stellate cells activation by regulating the ferroptosis signaling pathway. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1869(7), 166750. https://doi.org/10.1016/j.bbadis.2023.166750

Vancouver

Kitsugi K, Noritake H, Matsumoto M, Hanaoka T, Umemura M, Yamashita M, et al. Simvastatin inhibits hepatic stellate cells activation by regulating the ferroptosis signaling pathway. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2023;1869(7):166750. doi:10.1016/j.bbadis.2023.166750

BibTeX
@article{Kitsugi2023,
  author = {Kitsugi, Kensuke and Noritake, Hidenao and Matsumoto, Moe and Hanaoka, Tomohiko and Umemura, Masahiro and Yamashita, Maho and Takatori, Shingo and Ito, Jun and Ohta, Kazuyoshi and Chida, Takeshi and Suda, Takafumi and Kawata, Kazuhito},
  title = {Simvastatin inhibits hepatic stellate cells activation by regulating the ferroptosis signaling pathway},
  journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
  year = {2023},
  volume = {1869},
  number = {7},
  pages = {166750},
  doi = {10.1016/j.bbadis.2023.166750}
}
Kostenlos starten →